Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5772964

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCN(CCO)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
KDM4E B2RXH2 1/20 0.42
CACNA1F O60840 2/20 0.42
DRD4 P21917 2/20 0.42
DRD5 P21918 2/20 0.42
HRH2 P25021 2/20 0.42
ADRA1D P25100 2/20 0.42
HTR2A P28223 2/20 0.42
HTR7 P34969 2/20 0.42
ADRA1A P35348 2/20 0.42
HRH1 P35367 2/20 0.42
ADRA1B P35368 2/20 0.42
OPRM1 P35372 2/20 0.42
DRD3 P35462 2/20 0.42
OPRD1 P41143 2/20 0.42
OPRK1 P41145 2/20 0.42
HTR6 P50406 2/20 0.42
CACNA1D Q01668 2/20 0.42
SLC6A3 Q01959 2/20 0.42
CACNA1S Q13698 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776847 0.90 MDM2 (0.39) TSHRCACNA1FDRD4DRD5HRH2
Trifluoroacetic Acid SCHEMBL5776834 0.89 HTT (0.46) CACNA1FDRD4DRD5HRH2ADRA1D
Trifluoroacetic Acid SCHEMBL5776822 0.87 DPP8 (0.50) TSHRDPP8DPP7GFERMEN1
Trifluoroacetic Acid SCHEMBL5777433 0.87 GFER (0.53) TSHRGFERMEN1KMT2A
SCHEMBL5907061 0.85 HTR2A (0.39) CACNA1FDRD4DRD5HRH2ADRA1D
Trifluoroacetic Acid SCHEMBL5772610 0.85 GFER (0.53) TSHRGFERMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5770006 0.85 KDM4E (0.39) TSHRKDM4ECACNA1FDRD4DRD5
Trifluoroacetic Acid SCHEMBL5776691 0.83 GRM5 (0.48) TSHRKDM4EDRD4HTR2AHTR7
Trifluoroacetic Acid SCHEMBL5773395 0.83 LMNA (0.48) TSHRKDM4EADRA1DHTR2AADRA1A
Trifluoroacetic Acid SCHEMBL5773386 0.83 LMNA (0.48) TSHRKDM4EADRA1DHTR2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR TSHR 534/4885KDM4E 3953/4885CACNA1F 1585/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 TSHR 583/4885KDM4E 3347/4885CACNA1F 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.